Michael Bartholow, PharmD, CACP

home / authors / michael-bartholow-pharmd-cacp

Articles

Top Drugs of 2015

Top Drugs of 2015

Michael Bartholow, PharmD, CACP
July 18th 2016

Medication spending grew by 12.2% in 2015, totaling approximately $425 billion.

Read More

Top Drugs of 2014

Top Drugs of 2014

Michael Bartholow, PharmD, CACP
July 13th 2015

This analysis of the top drugs by prescriptions dispensed and total sales reveals key trends in today's pharmaceutical market.

Read More

Site Logo

Top Drugs of 2013

Michael Bartholow, PharmD, CACP
July 11th 2014

This analysis of the top drugs by prescriptions dispensed and total sales reveals key trends in today's pharmaceutical market.

Read More

Site Logo

Top 200 Drugs of 2011

Michael Bartholow, PharmD, CACP
July 10th 2012

An analysis of the top 200 drugs by prescriptions dispensed and total sales reveals key trends in today's pharmaceutical market.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD